Martingale Asset Management’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
VCM
NTCM
Martingale Asset Management's IRMD Position: Q1 2026 in Review
Martingale Asset Management reduced its iRadimed (IRMD) stake by 5% in Q1 2026, selling an estimated $64K and leaving 12,230 shares worth $1.18M. The position accounts for 0.03% of the portfolio, ranked #455.
Martingale Asset Management first reported a position in IRMD in Q3 2020 and has held it in 19 quarters since. The position peaked at $1.25M in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.
- Martingale Asset Management held 12,230 shares of iRadimed worth $1.18M as of Q1 2026.
- Martingale Asset Management sold 640 iRadimed shares in Q1 2026, an estimated $64K.
- iRadimed made up 0.03% of Martingale Asset Management's portfolio in Q1 2026, its #455 holding.
- Martingale Asset Management first reported a position in iRadimed in Q3 2020 and has held it in 19 quarters since.
- Martingale Asset Management's iRadimed position peaked at $1.25M in Q4 2025.
- 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.
Based on Martingale Asset Management's 13F filing for Q1 2026, filed 13 May 2026.